Resources
Download this reportCombating Tuberculosis
Inside this issue
• Discoveries about basic TB biology are guiding researchers
• Frontline workers have untapped knowledge relevant to everything from clinic design to treatment - -
Content
Fight needs money and leadership
Financial austerity is a broad threat to progress, with cuts in healthcare budgets and international donor support, writes Andrew Jack
Drug supply: Business retreats from unattractive market
Orders are fragmented and there is pressure to price products as cheaply as possible, notes Andrew Jack
Patient care: Nurses are underused and undervalued
Frontline workers have untapped knowledge relevant to everything from clinic design to treatment, says Sarah Murray
New medicines: Knowledge of the enemy will widen our armoury
Recent discoveries about the basic biology of TB should help to improve treatment, writes Clive Cookson
Diagnostics: Molecular test offers hope for detecting drug resistance
The WHO has endorsed ‘Xpert’ but the machines are expensive, says Charis Gresser
Treatment: Surgery can help in some difficult cases
Russia has always been wedded to an approach that can be useful against resistant strains, writes Andrew Jack
Romania: ‘The future looks really dark’
Global Fund money runs out next year, notes Andrew Jack
India: Rural healers can help with treatment
The country has made big strides in improving diagnosis and treatment, writes Amy Kazmin
New vaccines: A financial booster
Scientists are rapidly coming up with new vaccine candidates to supplement and then replace BCG, writes Clive Cookson
Case study: Eradication becomes harder as cases dwindle
Now the disease is rarer, fewer doctors can diagnose it, says Alan Rappeport
